SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000936392-08-000326
Filing Date
2008-05-07
Accepted
2008-05-07 17:26:50
Documents
5
Period of Report
2008-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a40585e8vk.htm 8-K 18127
2 EXHIBIT 1.1 a40585exv1w1.htm EX-1.1 168997
3 EXHIBIT 5.1 a40585exv5w1.htm EX-5.1 6703
4 EXHIBIT 10.1 a40585exv10w1.htm EX-10.1 36031
5 GRAPHIC a40585a4058501.gif GRAPHIC 4639
  Complete submission text file 0000936392-08-000326.txt   237954
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 08811120
SIC: 2836 Biological Products, (No Diagnostic Substances)